EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Seco-Duocarmycin SA Augments the Impact of Proton Radiation on Human Glioblastoma Cells

Ann Morcos, Joab Galvan Bustillos, Yeonkyu Jung iD, Ryan N Fuller iD, Antonella Bertucci, David Caba Molina iD, Amy Nguyen, Quanqing Zhang, Kristopher E Boyle, William H R Langridge, Marcelo Vazquez, Nathan R Wall iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27031532 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Ann Morcos und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Medicine, James M. Slater, MD Proton Treatment & Research Center, Loma Linda University Health, Loma Linda, CA 92350, USA. Hauptthemen laut MEDLINE: Glioblastoma, Indoles, Brain Neoplasms, Proton Therapy. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Loma Linda University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma multiforme (GBM) is an aggressive brain tumor with limited treatment options and poor survival outcomes. This study evaluated the anticancer potential of seco-duocarmycin SA (seco-DSA), a potent DNA-alkylating agent, alone and in combination with proton radiation in human GBM cell lines. Human glioblastoma cell lines T98G and LN18 were treated with varying concentrations of seco-DSA, proton radiation doses (2, 4, or 8 Gy), or both. Proton irradiation was delivered with a 250-MeV beam. Clonogenic survival, cell proliferation, and cell cycle distribution were analyzed using colony formation and flow cytometry assays. Proteomic analysis of LN18 cells was performed by LC-MS/MS followed by bioinformatic pathway analysis. Statistical significance was determined using a two-tailed unpaired t-test (p ≤ 0.05), and Bliss synergy scores were calculated to assess treatment interactions. Combination therapy produced additive and synergistic inhibition of colony formation and enhanced G2/M phase arrest compared with either treatment alone. Apoptosis and necrosis increased modestly but did not fully account for observed cytotoxicity. Proteomic profiling revealed differential expression of proteins involved in DNA repair, apoptosis, and senescence, indicating that seco-DSA broadened radiation-induced stress responses. Seco-DSA potentiates the cytotoxic effects of proton radiation in GBM cells through enhanced clonogenic inhibition and modulation of cell cycle and DNA repair pathways. These findings support seco-DSA as a promising radiosensitizer for further preclinical evaluation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaIndolesBrain NeoplasmsProton TherapyHumansCell Line, TumorApoptosisCell ProliferationDuocarmycinsProtonsProteomicsCell Survival

Stichwörter der Autor:innen

cellular mechanismsglioblastoma multiformepotencyproton radiationseco-DSAsynergy

Substanzen

DuocarmycinsProtonsIndoles

Autor:innen und Institutionen

  • Department of Radiation Medicine, James M. Slater, MD Proton Treatment & Research Center, Loma Linda University Health, Loma Linda, CA 92350, USA.
  • Division of Human Anatomy, Department of Pathology and Human Anatomy, Loma Linda University School of Medicine, Loma Linda, CA 92350, USA.
  • Division of Surgical Oncology, Department of Surgery, Riverside University Health System-University of California Riverside, Moreno Valley, CA 92555, USA.
  • Department of Biological Sciences, California Baptist University, Riverside, CA 92504, USA.
  • Nuclear Response & Analysis, Canadian Nuclear Laboratories, Chalk River, ON K0J 1J0, Canada.
  • Proteomics Core, Institute for Integrative Genome Biology, University of California, Riverside, CA 92521, USA.

ORCID-Profile: Yeonkyu Jung, Ryan N Fuller, David Caba Molina, Nathan R Wall

Förderung

  • Loma Linda University

Zitieren

APA

Morcos, A., Galvan Bustillos, J., Jung, Y., Fuller, R. N., Bertucci, A., Caba Molina, D., Nguyen, A., Zhang, Q., Boyle, K. E., Langridge, W. H. R., Vazquez, M., & Wall, N. R. (2026). Seco-Duocarmycin SA Augments the Impact of Proton Radiation on Human Glioblastoma Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27031532

Vancouver

Morcos A, Galvan Bustillos J, Jung Y, Fuller RN, Bertucci A, Caba Molina D, et al. Seco-Duocarmycin SA Augments the Impact of Proton Radiation on Human Glioblastoma Cells. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27031532

BibTeX
@article{Morcos2026,
  author = {Morcos, Ann and Galvan Bustillos, Joab and Jung, Yeonkyu and Fuller, Ryan N and Bertucci, Antonella and Caba Molina, David and Nguyen, Amy and Zhang, Quanqing and Boyle, Kristopher E and Langridge, William H R and Vazquez, Marcelo and Wall, Nathan R},
  title = {Seco-Duocarmycin SA Augments the Impact of Proton Radiation on Human Glioblastoma Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27031532}
}
Kostenlos starten →